BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9674796)

  • 1. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.
    Heyman A; Fillenbaum GG; Welsh-Bohmer KA; Gearing M; Mirra SS; Mohs RC; Peterson BL; Pieper CF
    Neurology; 1998 Jul; 51(1):159-62. PubMed ID: 9674796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
    Snowdon DA; Greiner LH; Mortimer JA; Riley KP; Greiner PA; Markesbery WR
    JAMA; 1997 Mar; 277(10):813-7. PubMed ID: 9052711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease.
    Lee JH; Olichney JM; Hansen LA; Hofstetter CR; Thal LJ
    Arch Neurol; 2000 Oct; 57(10):1474-9. PubMed ID: 11030800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.
    Kraybill ML; Larson EB; Tsuang DW; Teri L; McCormick WC; Bowen JD; Kukull WA; Leverenz JB; Cherrier MM
    Neurology; 2005 Jun; 64(12):2069-73. PubMed ID: 15985574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.
    Honig LS; Kukull W; Mayeux R
    Neurology; 2005 Feb; 64(3):494-500. PubMed ID: 15699381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.
    Heyman A; Fillenbaum GG; Gearing M; Mirra SS; Welsh-Bohmer KA; Peterson B; Pieper C
    Neurology; 1999 Jun; 52(9):1839-44. PubMed ID: 10371532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological assessment of Alzheimer's disease: the experience of the Consortium to Establish a Registry for Alzheimer's Disease.
    Mirra SS
    Int Psychogeriatr; 1997; 9 Suppl 1():263-8; discussion 269-72. PubMed ID: 9447447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease with and without cerebral infarcts.
    Del Ser T; Hachinski V; Merskey H; Munoz DG
    J Neurol Sci; 2005 Apr; 231(1-2):3-11. PubMed ID: 15792814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
    Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
    Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.
    Hulette C; Mirra S; Wilkinson W; Heyman A; Fillenbaum G; Clark C
    Neurology; 1995 Nov; 45(11):1991-5. PubMed ID: 7501147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    Nerg O; Junkkari A; Hallikainen I; Rauramaa T; Luikku A; Hiltunen M; Jääskeläinen JE; Leinonen V; Hänninen T; Koivisto A
    J Alzheimers Dis; 2021; 81(3):1117-1130. PubMed ID: 33896842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
    Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
    J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.
    Mirra SS; Heyman A; McKeel D; Sumi SM; Crain BJ; Brownlee LM; Vogel FS; Hughes JP; van Belle G; Berg L
    Neurology; 1991 Apr; 41(4):479-86. PubMed ID: 2011243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.
    Rossetti HC; Munro Cullum C; Hynan LS; Lacritz LH
    Alzheimer Dis Assoc Disord; 2010; 24(2):138-42. PubMed ID: 20505431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.